Show simple item record

dc.contributor.authorGrossi, Carlota M.
dc.contributor.authorRichardson, Kathryn
dc.contributor.authorFox, Chris
dc.contributor.authorMaidment, Ian
dc.contributor.authorSteel, Nicholas
dc.contributor.authorLoke, Yoon K.
dc.contributor.authorArthur, Antony
dc.contributor.authorMyint, Phyo Kyaw
dc.contributor.authorCampbell, Noll
dc.contributor.authorBoustani, Malaz
dc.contributor.authorRobinson, Louise
dc.contributor.authorBrayne, Carol
dc.contributor.authorMatthews, Fiona E.
dc.contributor.authorSavva, George M.
dc.date.accessioned2019-10-23T14:55:02Z
dc.date.available2019-10-23T14:55:02Z
dc.date.issued2019-10-21
dc.identifier.citationGrossi , C M , Richardson , K , Fox , C , Maidment , I , Steel , N , Loke , Y K , Arthur , A , Myint , P K , Campbell , N , Boustani , M , Robinson , L , Brayne , C , Matthews , F E & Savva , G M 2019 , ' Anticholinergic and benzodiazepine medication use and risk of incident dementia : a UK cohort study ' , BMC Geriatrics , vol. 19 , 276 . https://doi.org/10.1186/s12877-019-1280-2en
dc.identifier.issn1471-2318
dc.identifier.otherPURE: 147569965
dc.identifier.otherPURE UUID: 199df2f3-e0af-4770-a088-2a281e93d736
dc.identifier.otherPubMed: 31638906
dc.identifier.otherScopus: 85073708327
dc.identifier.otherWOS: 000491310400002
dc.identifier.urihttps://hdl.handle.net/2164/13152
dc.descriptionAvailability of data and materials Data can be shared through application. For further information please refer to the application forms on the website http://www.cfas.ac.uk/cfas-i/data/#cfasi-data-request. Acknowledgments We would like to thank the MRC CFAS study group for data collection and management. We are also grateful to all respondents, their families and their primary care teams for their participation in the MRC CFAS. We would like to thank Mr. Barry Plumpton, Mrs. Ann McLauchlan, Mrs. Barbara di Vita, and Mrs. Gloria Swan for providing valuable assistance in interpretation and oversight as Alzheimer’s Society Research Network Volunteers. Funding This work was supported by the UK Alzheimer’s Society [AS-PG-2013-017]. The funders had no role in the design of the study or the interpretation of the findings.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofBMC Geriatricsen
dc.rights© The Author(s). 2019 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectAlzheimer diseaseen
dc.subjectCognitionen
dc.subjectDementiaen
dc.subjectCohort studyen
dc.subjectBenzodiazepinesen
dc.subjectCholinergic antagonistsen
dc.subjectDRUGSen
dc.subjectDISEASEen
dc.subjectOLDERen
dc.subjectCOGNITIVE IMPAIRMENTen
dc.subjectPREVALENCEen
dc.subjectR Medicineen
dc.subjectGeriatrics and Gerontologyen
dc.subjectAlzheimers Research UKen
dc.subjectAS-PG-2013-017en
dc.subjectSupplementary data availableen
dc.subject.lccRen
dc.titleAnticholinergic and benzodiazepine medication use and risk of incident dementia : a UK cohort studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s12877-019-1280-2
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85073708327&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record